Skip to main content
. Author manuscript; available in PMC: 2016 Sep 20.
Published in final edited form as: Stat Med. 2016 Apr 18;35(21):3760–3775. doi: 10.1002/sim.6966

Table 1.

Patient sequence and dose levels for Neuenschwander et al. 2008 study for the first 10 dose levels (no data were provided for dose levels 11-15). Probability mass at each level for prior and posterior shown in bold

Doses (mg) 1.0 2.5 5 10 15 20 25 30 40 50

No. of patients 3 4 5 4 0 0 2 - - -
No. of DLTs 0 0 0 0 - - 2 - - -

prior .17 .02 .01 .01 .01 .02 .04 .07 .09 .56
posterior .01 .01 .01 .01 .02 .03 .10 .28 .37 .19